Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895942511> ?p ?o ?g. }
- W2895942511 endingPage "1762" @default.
- W2895942511 startingPage "1754" @default.
- W2895942511 abstract "Background This study was designed to assess the clinical efficacy and toxicity of apatinib (YN968D1) as third or subsequent‐line treatment for stage III/IV non‐small cell lung cancer (NSCLC). Methods A total of 100 patients with advanced NSCLC who were treated with apatinib at a daily dose of 250/425/500 mg at Shandong Cancer Hospital from January 2016 to June 2018 were enrolled in our study. The objective response, disease control, and median progression‐free survival rates were reviewed and evaluated. Univariate and multivariate analyses were performed to determine the prognostic factors. The main adverse events were evaluated per the Common Terminology Criteria for Adverse Events version 4.0. Results All patients were assessable for response. No complete responses were observed, 11 patients achieved a partial response, and 56 showed stable disease. The objective response rate was 11.0%, the disease control rate was 67.0%, and the median progression‐free survival was 2.93 months (95% confidence interval 2.07–3.87). In Cox regression analysis, the Eastern Cooperative Oncology Group performance status score (hazard ratio 1.799; P < 0.05) and smoking history (hazard ratio 1.958; P < 0.05) were predictive indicators for apatinib treatment efficacy. Treatment‐related adverse events were tolerated, predictable, reversible, and controllable. Conclusion Apatinib was found to be both effective and safe in advanced NSCLC patients without a genetic driver mutation who experienced progression after two or more lines of chemotherapy treatment." @default.
- W2895942511 created "2018-10-26" @default.
- W2895942511 creator A5011703930 @default.
- W2895942511 creator A5012541893 @default.
- W2895942511 creator A5030611214 @default.
- W2895942511 creator A5081882565 @default.
- W2895942511 creator A5085409628 @default.
- W2895942511 date "2018-10-19" @default.
- W2895942511 modified "2023-10-01" @default.
- W2895942511 title "Clinical investigation of the efficacy and toxicity of apatinib (YN968D1) in stage III/IV non-small cell lung cancer after second-line chemotherapy treatment: A retrospective study" @default.
- W2895942511 cites W1505632988 @default.
- W2895942511 cites W1816099873 @default.
- W2895942511 cites W1841624799 @default.
- W2895942511 cites W1972053328 @default.
- W2895942511 cites W1973615073 @default.
- W2895942511 cites W1978139448 @default.
- W2895942511 cites W1999464994 @default.
- W2895942511 cites W2000292756 @default.
- W2895942511 cites W2015328086 @default.
- W2895942511 cites W2026151657 @default.
- W2895942511 cites W2032242790 @default.
- W2895942511 cites W2038533540 @default.
- W2895942511 cites W2054841768 @default.
- W2895942511 cites W2061305612 @default.
- W2895942511 cites W2064384115 @default.
- W2895942511 cites W2096704713 @default.
- W2895942511 cites W2100785570 @default.
- W2895942511 cites W2104759721 @default.
- W2895942511 cites W2117692326 @default.
- W2895942511 cites W2117791747 @default.
- W2895942511 cites W2141236760 @default.
- W2895942511 cites W2145092426 @default.
- W2895942511 cites W2145835533 @default.
- W2895942511 cites W2153886286 @default.
- W2895942511 cites W2166573361 @default.
- W2895942511 cites W2170030318 @default.
- W2895942511 cites W2180834360 @default.
- W2895942511 cites W2198210452 @default.
- W2895942511 cites W2293170306 @default.
- W2895942511 cites W2296028965 @default.
- W2895942511 cites W2400328547 @default.
- W2895942511 cites W2403980124 @default.
- W2895942511 cites W2519161237 @default.
- W2895942511 cites W2545845599 @default.
- W2895942511 cites W2588675203 @default.
- W2895942511 cites W2594982122 @default.
- W2895942511 cites W2606203880 @default.
- W2895942511 cites W2618360530 @default.
- W2895942511 cites W2745144228 @default.
- W2895942511 cites W2747382292 @default.
- W2895942511 cites W2749202673 @default.
- W2895942511 cites W2761064712 @default.
- W2895942511 cites W2766366470 @default.
- W2895942511 cites W2768885730 @default.
- W2895942511 cites W2773715282 @default.
- W2895942511 cites W2778659609 @default.
- W2895942511 cites W2781322640 @default.
- W2895942511 cites W2781525129 @default.
- W2895942511 cites W2790519321 @default.
- W2895942511 cites W2793195269 @default.
- W2895942511 cites W2802688581 @default.
- W2895942511 cites W2803093107 @default.
- W2895942511 cites W2805443924 @default.
- W2895942511 cites W2806694019 @default.
- W2895942511 cites W2810038861 @default.
- W2895942511 cites W29173195 @default.
- W2895942511 cites W2980384030 @default.
- W2895942511 cites W2982069986 @default.
- W2895942511 cites W4234236664 @default.
- W2895942511 cites W785602768 @default.
- W2895942511 doi "https://doi.org/10.1111/1759-7714.12898" @default.
- W2895942511 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6275827" @default.
- W2895942511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30338916" @default.
- W2895942511 hasPublicationYear "2018" @default.
- W2895942511 type Work @default.
- W2895942511 sameAs 2895942511 @default.
- W2895942511 citedByCount "14" @default.
- W2895942511 countsByYear W28959425112019 @default.
- W2895942511 countsByYear W28959425112020 @default.
- W2895942511 countsByYear W28959425112021 @default.
- W2895942511 countsByYear W28959425112022 @default.
- W2895942511 crossrefType "journal-article" @default.
- W2895942511 hasAuthorship W2895942511A5011703930 @default.
- W2895942511 hasAuthorship W2895942511A5012541893 @default.
- W2895942511 hasAuthorship W2895942511A5030611214 @default.
- W2895942511 hasAuthorship W2895942511A5081882565 @default.
- W2895942511 hasAuthorship W2895942511A5085409628 @default.
- W2895942511 hasBestOaLocation W28959425111 @default.
- W2895942511 hasConcept C121608353 @default.
- W2895942511 hasConcept C126322002 @default.
- W2895942511 hasConcept C141071460 @default.
- W2895942511 hasConcept C143998085 @default.
- W2895942511 hasConcept C146357865 @default.
- W2895942511 hasConcept C151730666 @default.
- W2895942511 hasConcept C197934379 @default.
- W2895942511 hasConcept C207103383 @default.
- W2895942511 hasConcept C2776256026 @default.
- W2895942511 hasConcept C2776694085 @default.